All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @meghanmctavish on TikTok · 89s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @meghanmctavish's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00good news. I have some good news. I have been taking GHK-Cu peptide injected in my
  2. 0:06butt for about 10 weeks now. I'm not gonna lie, skin is skinning. This is no filter,
  3. 0:13hardly any makeup, maybe some setting spray. And everything is plump and the way I can describe
  4. 0:19it is it just feels juicier. That's the only way I can explain it. It feels moisturized,
  5. 0:26more youthful and more even. GHK-Cu is called the glow peptide or it's one of the glow peptides.
  6. 0:33It's a naturally occurring amino acid that your body has that helps promote cell turnover,
  7. 0:40long hair, things like that. But when you turn 40 everything drops. So what you're doing when
  8. 0:45you inject GHK-Cu is you just are shoving it back in and topping yourself up. Also just received a
  9. 0:51vial of NAD which I'm really excited to try because as a PMDD girly I suffer with brain fog.
  10. 0:58About a week once a month and NAD is amazing for covering post-chim brain fog. Just more alertness,
  11. 1:05being more awake, having stamina. I'm super excited to try that. Now I make sure before I promote
  12. 1:12anything to anyone I do it and so the people that I link to in the bottom in the caption are
  13. 1:19people that I get it from. They're from Australia and I trust them and I use them so
  14. 1:26if you're curious take a look at them.

@meghanmctavish's GHK-Cu peptide claims, fact-checked

Meghan | The Plotline©

TikTok creator

7.0K viewsWatch on TikTok

Quick answer

GHK-Cu is a naturally occurring copper-binding tripeptide with in vitro and animal evidence supporting collagen synthesis, antioxidant gene activation, and skin remodeling pathways. Human clinical data for injectable GHK-Cu as a cosmetic or systemic intervention is not established in peer-reviewed literature, and the pharmacokinetics of intramuscular administration in healthy adults remain uncharacterized. The creator's concurrent promotion of injectable NAD for PMDD-related cognitive symptoms represents a separate, also unsubstantiated clinical claim with no controlled trial support.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @meghanmctavish's GHK-Cu peptide claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@meghanmctavish's GHK-Cu peptide claims, fact-checked" from Meghan | The Plotline©. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GHK-Cu is a naturally occurring copper-binding tripeptide with in vitro and animal evidence supporting collagen synthesis, antioxidant gene activation, and skin remodeling pathways.

The reason this review is not generic is the source wording and the canonical claim label "peptides no makeup just 8 weeks on ghk cu i get mine from alpha pe." In this clip, the useful excerpt is: "good news." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 2018 paper in Biomolecules (Pickart, Vasquez-Soltero, and Margolina) documents GHK-Cu's gene-level effects on skin remodeling, but these findings are in vitro and do not constitute evidence for injectable cosmetic use in humans.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GHK-Cu is a naturally occurring copper-binding tripeptide with in vitro and animal evidence supporting collagen synthesis, antioxidant gene activation, and skin remodeling pathways.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GHK-Cu is a naturally occurring copper-binding tripeptide with in vitro and animal evidence supporting collagen synthesis, antioxidant gene activation, and skin remodeling pathways. Human clinical data for injectable GHK-Cu as a cosmetic or systemic intervention is not established in peer-reviewed literature, and the pharmacokinetics of intramuscular administration in healthy adults remain uncharacterized. The creator's concurrent promotion of injectable NAD for PMDD-related cognitive symptoms represents a separate, also unsubstantiated clinical claim with no controlled trial support.
  • GHK-Cu is a tripeptide-copper complex, not an amino acid. Misidentifying its basic biochemistry in the context of an injectable promotion is a meaningful error.
  • A 2018 paper in Biomolecules (Pickart, Vasquez-Soltero, and Margolina) documents GHK-Cu's gene-level effects on skin remodeling, but these findings are in vitro and do not constitute evidence for injectable cosmetic use in humans.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • GHK-Cu is a tripeptide-copper complex, not an amino acid. Misidentifying its basic biochemistry in the context of an injectable promotion is a meaningful error.
  • A 2018 paper in Biomolecules (Pickart, Vasquez-Soltero, and Margolina) documents GHK-Cu's gene-level effects on skin remodeling, but these findings are in vitro and do not constitute evidence for injectable cosmetic use in humans.
  • No published randomized controlled trial has examined intramuscular or subcutaneous GHK-Cu injections for skin quality outcomes in healthy adults.
  • Injectable peptides sourced from unregulated overseas suppliers are not subject to mandatory sterility, purity, or concentration testing. Both the FDA and TGA have issued warnings about risks from unregulated injectable peptides.
  • Self-reported skin improvements after 8 to 10 weeks cannot be reliably attributed to a single injectable compound without controlling for sleep, hydration, stress, and placebo effects.
  • The NAD-for-PMDD-brain-fog claim has no supporting clinical trial evidence and should not be treated as an established therapeutic application.
  • Individuals interested in peptide therapy for skin or cognitive concerns should consult a licensed physician or compounding pharmacy before sourcing or self-injecting any unregulated compound.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @meghanmctavish actually say?

Meghan claims she has been injecting GHK-Cu into her gluteal muscle for ten weeks and attributes noticeably plumper, more even, "juicier" skin to the peptide. She describes GHK-Cu as "a naturally occurring amino acid that your body has" and says that injecting it is like "shoving it back in and topping yourself up." She also pivots to plug NAD injections for PMDD-related brain fog, and discloses she is affiliated with the Australian supplier she recommends.

A few things to note right away: GHK-Cu is not an amino acid. It is a tripeptide-copper complex, meaning it is made of three amino acids bound to a copper ion. That is not a trivial distinction. She also switches mid-video between two separate compounds, two separate symptom claims, and a commercial referral code, which makes this video doing a lot of work at once.

Does the science back this up?

Partially, yes, but the evidence is mostly preclinical or in vitro, and what human data exists is largely topical, not injectable. The leap from "promising in a petri dish" to "inject this in your butt for glowing skin" is not one the published literature has made.

GHK-Cu does have a reasonably interesting research profile. In vitro studies show it can stimulate collagen synthesis, activate antioxidant pathways, and influence gene expression related to skin repair. A 2009 review by Pickart and Margolina in the journal Archives of Dermatological Research documented these effects thoroughly. A 2018 paper by Pickart, Vasquez-Soltero, and Margolina in Biomolecules extended those findings, showing GHK-Cu upregulates genes associated with skin remodeling. However, these are not clinical trials of injectable GHK-Cu in humans. Most human studies involve topical formulations, and even those are small and industry-adjacent. There is no published randomized controlled trial of subcutaneous or intramuscular GHK-Cu injection for cosmetic skin outcomes in healthy adults.

What did they get wrong (or right)?

Wrong: calling GHK-Cu an amino acid. It is a copper-binding tripeptide. This matters because it changes how the molecule behaves, how it is absorbed, and how it should be discussed in a medical context. Getting the basic biochemistry wrong while promoting injectable use is a problem.

Also wrong: the framing that injecting GHK-Cu is simply "topping yourself up." Endogenous GHK-Cu levels do decline with age, but the assumption that supplementing exogenous peptide via injection replicates or restores that signaling system in a predictable way is not established. Pharmacokinetics of injected GHK-Cu in humans are not well characterized in the published literature.

Partially right: GHK-Cu is indeed associated with skin-relevant biological activity. The collagen and elastin synthesis signals are documented. And it is honest that she discloses personal use and a commercial relationship. That disclosure is more than most peptide influencers bother with.

The NAD claim for PMDD brain fog is essentially unverifiable from available evidence. NAD precursor research in neurological contexts is early-stage, and "covering post-brain fog" from PMDD is not a studied indication for injectable NAD.

What should you actually know?

If you are curious about GHK-Cu, the honest answer is: the biology is interesting, the human evidence is thin, and injecting an unregulated peptide sourced from an overseas supplier carries real risks that this video does not address. Injectable peptides sold outside a licensed pharmacy or compounding facility are not subject to sterility testing, purity verification, or dose standardization. That is not a hypothetical concern. The FDA and TGA have both flagged risks from unregulated injectable peptides, including contamination and incorrect concentration.

Cosmetic outcomes after eight to ten weeks of any new routine are also notoriously hard to attribute. Sleep, hydration, stress reduction, placebo effect, and lighting all influence how skin looks and feels. Without a controlled comparison, "my skin feels juicier" is a personal observation, not evidence.

If you want to explore GHK-Cu, a conversation with a licensed dermatologist or compounding-pharmacy-affiliated physician is the appropriate starting point, not a TikTok affiliate code. The peptide may have a future in regulated aesthetic medicine. It is not there yet.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Meghan | The Plotline© · TikTok creator

7.0K views on this video

No makeup. Just 8 weeks on GHK-CU. I get mine from @Alpha Peptides Australia (use MEGHAN10 for 10% off) #peptideserum #peptideskincare #ghk

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu?

GHK-Cu is a tripeptide-copper complex, not an amino acid. Misidentifying its basic biochemistry in the context of an injectable promotion is a meaningful error.

What does the video say about a 2018 paper in biomolecules (pickart, vasquez-soltero,?

A 2018 paper in Biomolecules (Pickart, Vasquez-Soltero, and Margolina) documents GHK-Cu's gene-level effects on skin remodeling, but these findings are in vitro and do not constitute evidence for injectable cosmetic use in humans.

What does the video say about no published randomized controlled trial has examined intramuscular?

No published randomized controlled trial has examined intramuscular or subcutaneous GHK-Cu injections for skin quality outcomes in healthy adults.

What does the video say about injectable peptides sourced from unregulated overseas suppliers?

Injectable peptides sourced from unregulated overseas suppliers are not subject to mandatory sterility, purity, or concentration testing. Both the FDA and TGA have issued warnings about risks from unregulated injectable peptides.

What does the video say about self-reported skin improvements after 8 to 10 weeks cannot be?

Self-reported skin improvements after 8 to 10 weeks cannot be reliably attributed to a single injectable compound without controlling for sleep, hydration, stress, and placebo effects.

What does the video say about the nad-for-pmdd-brain-fog claim has no supporting clinical trial evidence?

The NAD-for-PMDD-brain-fog claim has no supporting clinical trial evidence and should not be treated as an established therapeutic application.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Meghan | The Plotline©, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.